Outcomes of stem cell transplant in children
Part of Blood & lymphatic, Cancer, Genetic & congenital clinical trials.
This study looks at how children who received a stem cell transplant at one hospital are doing. It aims to learn about their recovery and long-term results, which can help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stem cell transplant at this hospital
- You had the transplant for a blood disorder, cancer, or another condition
- Your medical records are complete and available
- You are a child or adolescent at the time of transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well patients do after receiving a stem cell transplant from a donor (called an allogeneic transplant). It aims to better understand the long-term outcomes and help improve care for future patients.
This study looks at the long-term health effects of hematopoietic (blood-forming) stem cell transplants. It may help doctors better understand and manage late side effects for children and teens after transplant.
This study looks at how children who had a stem cell transplant before puberty grow and develop hormones compared to children who had chemotherapy but no transplant. It aims to understand any long-term effects on growth and puberty.
This study follows children and teens who get a stem cell transplant to learn how lung problems develop over time. Your participation could help doctors better predict, prevent, and manage lung injury after transplant.
This study looks at how a stem cell transplant affects thinking and memory in children, and how the child's environment and physical abilities might help. Your family's participation could help find ways to support children's brain health after transplant.
This Phase 2 study tests a strong (myeloablative) stem cell transplant using donor stem cells (allogeneic transplant) for certain blood and bone marrow cancers. The goal is to see how well this approach works and whether it can improve outcomes for people who need transplant-level treatment.
Hear when a new Hematologic Disease and Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.